PRKAA1 and fatty liver disease: We observed that CC treatment markedly abrogated hepatic AMPK activity (Fig. 8A) and completely blocked the preventive roles of G1 on the progression of inflammation, hepatic steatosis, and fibrosis in female mice fed with the HFHC diet (Fig. 8, B–J).